One-Year Outcomes After Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention: The T-TIME Randomized Trial.
第一作者:
Annette M,Maznyczka
第一单位:
British Heart Foundation Glasgow Cardiovascular Research Centre (A.M.M., P.J.M., K.G.O., T.J.F., M.C.P., C.B.), University of Glasgow, United Kingdom.
作者:
主题词
老年人(Aged);冠状动脉疾病(Coronary Artery Disease);双盲法(Double-Blind Method);女(雌)性(Female);纤维蛋白溶解药(Fibrinolytic Agents);人类(Humans);男(雄)性(Male);中年人(Middle Aged);无复流现象(No-Reflow Phenomenon);前瞻性研究(Prospective Studies);危险因素(Risk Factors);血栓溶解疗法(Thrombolytic Therapy);时间因素(Time Factors);组织型纤溶酶原激活物(Tissue Plasminogen Activator);治疗结果(Treatment Outcome)
DOI
10.1161/CIRCINTERVENTIONS.119.008855
PMID
32069113
发布时间
2021-01-10
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文